Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB00359_DB00682> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB00359_DB00682 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00359_DB00682 label "DDI between Sulfadiazine and Warfarin - Sulfadiazine, a strong CYP2C9 inhibitor, may decrease the metabolism of warfarin. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of warfarin if sulfadiazine is initiated, discontinued or dose changed. [drugbank_resource:DB00359_DB00682]" assertion.
- drugbank_resource:DB00359_DB00682 identifier "drugbank_resource:DB00359_DB00682" assertion.
- drugbank_resource:DB00359_DB00682 title "DDI between Sulfadiazine and Warfarin - Sulfadiazine, a strong CYP2C9 inhibitor, may decrease the metabolism of warfarin. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of warfarin if sulfadiazine is initiated, discontinued or dose changed." assertion.